FDA recommends discussing the opioid reversal medicine naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. Also consider prescribing naloxone to those at increased risk of opioid overdose.
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder
